Evaxion A (EVAX) Enterprise Value (2019 - 2026)
Evaxion A posted quarterly Enterprise Value of -$18.4 million for Q1 2026, down 3.35% year-on-year from -$19.1 million in Q1 2025, and up 20.63% on a QoQ basis from -$23.2 million in Q4 2025.
Evaxion A (EVAX) has 8 years of Enterprise Value data on file, last reported at -$18.4 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 3.35% year-over-year to -$18.4 million; the trailing twelve-month figure through Mar 2026 stood at -$18.4 million (down 3.35% YoY), and the FY2025 full-year result was -$23.2 million, down 290.36% from the prior year.
- Enterprise Value for Q1 2026 stood at -$18.4 million, up from -$23.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$11731.0 in Q1 2024 and bottomed at -$31.4 million in Q1 2022.
- The 5-year median for Enterprise Value is -$11.9 million (2022), against an average of -$12.5 million.
- The widest annual swing landed in 2024, when Enterprise Value surged 99.82%; it then slumped 152001.27% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$13.2 million in 2022, then soared by 57.65% to -$5.6 million in 2023, then decreased by 6.61% to -$6.0 million in 2024, then tumbled by 290.36% to -$23.2 million in 2025, then advanced by 20.63% to -$18.4 million in 2026.
- The last three Enterprise Value figures came in at -$18.4 million (Q1 2026), -$23.2 million (Q4 2025), and -$10.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.44 Mn |
| Dec 31, 2025 | -23.23 Mn |
| Sep 30, 2025 | -10.57 Mn |
| Jun 30, 2025 | -14.75 Mn |
| Mar 31, 2025 | -17.84 Mn |
| Dec 31, 2024 | -5.95 Mn |
| Jun 30, 2024 | -7.99 Mn |
| Mar 31, 2024 | -11,731.00 |
| Dec 31, 2023 | -5.58 Mn |
| Sep 30, 2023 | -2.61 Mn |
| Jun 30, 2023 | -2.90 Mn |
| Mar 31, 2023 | -6.35 Mn |
| Dec 31, 2022 | -13.18 Mn |
| Sep 30, 2022 | -17.85 Mn |
| Jun 30, 2022 | -21.50 Mn |
| Mar 31, 2022 | -31.41 Mn |
| Dec 31, 2021 | -32.17 Mn |
| Sep 30, 2021 | -11.94 Mn |
| Jun 30, 2021 | -18.80 Mn |
| Mar 31, 2021 | -26.96 Mn |
| Dec 31, 2020 | -5.83 Mn |
| Dec 31, 2019 | -9.56 Mn |